ERBB2 and neoplasm: Women with msPOCs more commonly had larger tumours (P < 0.001), node-positive disease (P < 0.001), HER2-positive subtypes (P = 0.011), high-grade tumours (P < 0.001), and had received preoperative systemic therapy (P < 0.001).